Kinex appoints COO
This article was originally published in Scrip
Executive Summary
Hong Kong and Buffalo, New York-based Kinex Pharmaceuticals has named current chief business officer Flint Besecker to the position of chief operating officer. Mr Besecker will have additional responsibility over Kinex's emerging global operating platforms in addition to all corporate business matters. He will report to Kinex's CEO Dr Johnson Lau. Mr Besecker is also a member of Kinex's board.
You may also be interested in...
Six New Molecules By 2030 – J&J’s Neuroscience Strategy
Can neuroscience be precise? Peter Fang, worldwide VP of neuroscience, explains J&J's approach to precision medicine in Alzheimer’s disease, depression and other neurological conditions.
Accessing Venture Debt From The EIB
Tips from Gergely Krajcsi, senior investment officer at the European Investment Bank, on how biotechs can access loans for faster growth.
In Vivo's 2024 Rising Leaders At A Glance
Top 30 leaders: see the list of industry influencers highlighted in the fifth edition of In Vivo's Rising Leaders series.